Inventor · disambiguated record
William Dougall
Also filed as: DOUGALL WILLIAM C
5 granted patents·6 pending applications·285 citations·filing 1998–2008
86Inventor score
Files withIMMUNEX CORP7
Top patents by PatentIndex Score
11 records- 0196US6537763B2Receptor activator of NF-κBIMMUNEX CORP·Filed 2001·Granted Mar 25, 2003·64 cites·12 claims
- 0293US6528482B1Receptor activator of NF-κBIMMUNEX CORP·Filed 1999·Granted Mar 4, 2003·62 cites·10 claims
- 0392US6271349B1Receptor activator of NF-κBIMMUNEX CORP·Filed 1998·Granted Aug 7, 2001·132 cites·4 claims
- 0487US6884598B2Screening assays for agonists and antagonists of receptor activator of NF-κBIMMUNEX CORP·Filed 2001·Granted Apr 26, 2005·18 cites·25 claims
- 0584US7572594B2Screening assays for agonists or antagonists or receptor activator of NF-κBIMMUNEX CORP·Filed 2005·Granted Aug 11, 2009·9 cites·19 claims
- 0667US2005131648A1Screening assays for agonists or antagonists of CD40 signalingIMMUNEX CORP·Filed 2004·Application pending·0 cites
- 0758US2003165985A1Methods for identifying compounds that antagonize cd40 signalingFiled 2001·Application pending·0 cites
- 0857US2008200389A1Rank-ligand-induced sodium/proton antiporter polypeptidesIMMUNEX CORP·Filed 2008·Application pending·0 cites
- 0947US2004157771A1Rank-ligand-induced sodium/proton antiporter polypeptidesFiled 2003·Application pending·0 cites
- 1041US2003017151A1Therapeutic use of rank antagonistsFiled 2002·Application pending·0 cites
- 1139US2003021785A1Use of rank antagonists to treat cancerFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Dougall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →